Analysis:

## (a) Source Analysis

**Yahoo Finance Articles (Jan 20, Jan 18, 2026):**
- **Quality:** High - Major financial data aggregator
- **Key Facts:** Q2 2026 earnings expected $0.39 EPS (down 23.5% YoY), fiscal 2026 EPS forecast $1.70 (down 1.2%), fiscal 2027 $2.54 (up 49.4%). Stock up 4.9% past 52 weeks vs S&P 500's 16.9%. Market cap $19.5B.
- **Expert Opinions:** Goldman Sachs analyst Katherine Murphy initiated "Sell" rating with $26 target, citing margin pressure and limited profitability visibility (named source - highly credible). Consensus: "Moderate Buy" with $45.53 average target.
- **Date:** Recent and highly relevant

**CNBC Article (Nov 4, 2025):**
- **Quality:** High - Major financial news outlet
- **Key Facts:** Q1 fiscal revenue $5B (down 15% YoY), net income $168.3M (down 50%+ YoY). Q2 outlook $10-11B vs $7.83B analyst estimate. Stock up 55% YTD prior to report.
- **Opinions:** Unnamed analysts say Dell took market share (weak - unidentifiable source)
- **Date:** 3 months old - less relevant for Feb 2-14 window

**Yahoo Finance/GuruFocus (Nov 5, 2025):**
- **Quality:** High - Earnings call transcript summary
- **Key Facts:** Q1 revenue $5B (down 15% YoY, 13% QoQ), gross margin 9.5%, negative FCF -$950M, order backlog >$13B, Q2 guidance $10-11B, full year outlook $36B minimum
- **Date:** 3 months old

**24/7 Wall St. (Jan 18, 2026):**
- **Quality:** Moderate - Financial news site
- **Key Facts:** Stock jumped 11% on Jan 18 to $32.64, down 51% from 2025 highs, Q1 missed by 17.5%
- **Expert Opinions:** Goldman Sachs "Sell" rating with $26 target (corroborates other source). TSMC strong earnings cited as rally catalyst.
- **Date:** Recent (15 days before Feb 2)

**AskNews Articles (Feb 1-2, 2026):**
- **Quality:** Mixed - Various sources
- **Key Facts:** No SMCI-specific news. General market articles about Swiss SMI, Indian markets, IPOs. One article mentions SMCI as S&P 500 second-worst performer at $28.36 (5.8% decline) following Goldman downgrade.
- **Deep Research:** No new SMCI orders announced. Q2 earnings Feb 3 is key catalyst. AI infrastructure demand remains but competitive pressures persist.
- **Date:** Current (Feb 1-2, 2026)

**Historical Price Data:**
- **Robinhood/Yahoo:** Feb 2, 2026 close: $28.54-$30.12 range (sources vary slightly)
- **52-week range:** $25.71-$66.44
- **Recent trajectory:** Down from $30.96 (Jan 1) to ~$29 (Feb 2) = -6.4%

## (b) Evidence Analysis

**Strong Evidence (Large Shifts):**
1. **Goldman Sachs "Sell" rating with $26 target** - Multiple independent confirmations (Yahoo Finance, 24/7 Wall St.), named expert source, clear bearish thesis on margins dropping to 7.5% by 2026 from 15% in 2022. This is 9% below Feb 2 close of ~$29.
   - **Direction:** Strongly bearish
   - **Impact:** If Goldman's thesis is correct, stock should decline further

2. **Historical post-earnings pattern** - Outside view analysis documented 4 of last 5 earnings producing double-digit drops, with two specific cases: -16% (Aug 2025), -9% (Nov 2025)
   - **Direction:** Bearish for immediate post-Feb 3 reaction
   - **Impact:** High probability of gap-down Feb 4

3. **Feb 3 earnings as immediate catalyst** - Confirmed across multiple sources, occurs Day 2 of 12-day window
   - **Direction:** Creates binary outcome scenario
   - **Impact:** Dominates prediction timeframe

**Moderate Evidence:**
1. **Analyst consensus "Moderate Buy" with $45.53 target** - Represents 57% upside from ~$29, but conflicts with Goldman's bearish view and recent price action
   - **Direction:** Bullish long-term, but unclear for 12-day window
   - **Impact:** Suggests potential recovery IF earnings surprise positively

2. **Strong Q2 revenue guidance** - $10-11B vs $7.83B estimate (28-40% beat)
   - **Direction:** Bullish if met
   - **Impact:** Could override negative historical pattern

3. **Negative momentum** - Down 6.4% past month, down 51% from 2025 highs, near 52-week low
   - **Direction:** Bearish
   - **Impact:** Suggests continued weakness

4. **Order backlog >$13B** - From Nov 2025 earnings call
   - **Direction:** Bullish for fundamentals
   - **Impact:** Limited for 12-day window

**Weak Evidence:**
1. **TSMC earnings boost** - Jan 18 rally (+11%) attributed to TSMC results
   - **Direction:** Bullish
   - **Impact:** Temporary sentiment boost, not sustained

2. **"No new orders announced"** - From AskNews deep research
   - **Direction:** Neutral/slightly bearish
   - **Impact:** Absence of evidence, not evidence of absence

## (c) Timeframe Analysis

**Prediction Window:** 12 calendar days (Feb 2-14, 2026) = 9 trading days

**Critical Temporal Structure:**
- **Day 1 (Feb 2):** Baseline close ~$29
- **Day 2 (Feb 3):** Earnings after-market
- **Day 3 (Feb 4):** First trading response - historically gaps down sharply
- **Days 4-12 (Feb 5-14):** 8 trading days for recovery

**If Timeframe Halved (6 days to Feb 8):**
- Probability would DROP to ~25-30%
- Rationale: Captures immediate post-earnings decline with minimal recovery time
- Historical pattern shows sharp gaps that take weeks to recover

**If Timeframe Doubled (24 days to Feb 26):**
- Probability would RISE to ~45-50%
- Rationale: More time for mean reversion, recovery from oversold conditions
- Analyst targets ($45.53 consensus) become more achievable

**Key Scenario Analysis:**

*Scenario 1: Negative earnings reaction (65% probability)*
- Feb 4 gap-down of 8-12% → price drops to $25.50-$26.70
- Requires 8-13% recovery over 8 days to exceed $29
- Given Goldman's bearish thesis and margin concerns, recovery unlikely
- **Outcome:** Price remains below $29 on Feb 14

*Scenario 2: Positive earnings surprise (25% probability)*
- Revenue beats $11B guidance, margins stabilize
- Feb 4 gap-up of 5-8% → price rises to $30.50-$31.30
- Sustained above $29 through Feb 14
- **Outcome:** Price above $29 on Feb 14

*Scenario 3: Muted reaction (10% probability)*
- In-line results, stock drifts sideways
- Negative momentum continues, gradual decline to $27-28
- **Outcome:** Price below $29 on Feb 14

## (d) Justification

**Base Rate from Outside View:** 38%

**Adjustments for Inside View:**

**Factors Supporting DECREASE from 38%:**

1. **Goldman Sachs $26 target** (Strong Evidence): Most credible recent analyst opinion explicitly forecasts 10% downside from current levels. Their margin thesis (7.5% vs current 9.5%) is structural, not cyclical.
   - **Adjustment:** -5 percentage points

2. **No positive catalysts identified** (Moderate Evidence): AskNews deep research found no new orders, no positive developments. The "raising to BUY" mention in Yahoo Finance was unnamed/unverifiable.
   - **Adjustment:** -3 percentage points

3. **Current price near Goldman target** (Moderate Evidence): At $29, stock is only 10% above Goldman's $26 bear case, suggesting limited upside even if earnings are neutral
   - **Adjustment:** -2 percentage points

**Factors Supporting INCREASE from 38%:**

1. **Strong revenue guidance vs estimates** (Moderate Evidence): $10-11B vs $7.83B represents massive 28-40% beat potential. If delivered, could override bearish sentiment.
   - **Adjustment:** +4 percentage points

2. **Time for recovery** (Moderate Evidence): 8 trading days post-earnings allows for initial gap-down to be recovered if fundamentals prove solid
   - **Adjustment:** +3 percentage points

3. **Oversold conditions** (Weak Evidence): Down 51% from highs, near 52-week low suggests some investors may view as buying opportunity
   - **Adjustment:** +2 percentage points

**Net Adjustment:** -5 -3 -2 +4 +3 +2 = -1 percentage point

**Calibrated Inside View:** 38% - 1% = 37%

**Reality Check:**
- 37% implies ~2:1 odds against being higher
- This means in 100 similar scenarios, stock would be higher on Feb 14 only 37 times
- Given Goldman's explicit $26 target (10% below current), strong historical pattern of post-earnings declines, and lack of positive catalysts, this seems appropriately calibrated
- The 37% accounts for possibility of positive earnings surprise given strong revenue guidance

**Key Uncertainty:** The magnitude of earnings surprise. If SMCI delivers $11B+ revenue with stable margins, the 37% is too low. If they miss or margins compress further, 37% is too high.

## Probability Calibration

Starting from outside view base rate of 38%, I make a modest -1 percentage point adjustment to 37%.

**Reasoning for Small Adjustment:**
The outside view already incorporated:
- Historical post-earnings decline pattern (captured in -20pp from base 50%)
- Bearish expert sentiment (captured in -8pp)
- Recent negative momentum (captured in -5pp)

The inside view adds:
- **More specific bearish target** from Goldman at $26 (vs generic bearish sentiment)
- **Confirmation of no positive news** in immediate window (vs assumed absence)
- **More precise revenue guidance numbers** showing potential upside surprise

These factors roughly offset, resulting in minimal net adjustment. The 37% reflects:
- High confidence (65%) in immediate post-earnings decline
- Low confidence (35%) that any decline can be recovered within 8 trading days
- Very low probability (25%) of positive surprise strong enough to sustain gains

**Sensitivity Analysis:**
- If earnings beat by 30%+ with stable margins: Probability rises to 55-60%
- If earnings miss or margins compress: Probability falls to 15-20%
- If earnings in-line: Probability stays 30-35%

The 37% represents a probability-weighted average across these scenarios, with the negative scenario most likely given Goldman's recent downgrade and historical pattern.

## Checklist:

1. **Paraphrase:** Will SMCI close higher on Feb 14, 2026 than its Feb 2, 2026 close (~$29)? 12-day window with Feb 3 earnings.

2. **Base rate:** Outside view established 38% based on historical post-earnings patterns and bearish expert sentiment. Inside view adjusts minimally to 37%.

3. **Consistency:** "37 out of 100 times, SMCI closes higher on Feb 14 than Feb 2." This aligns with expectation that earnings will likely trigger decline that won't fully recover in 8 trading days.

4. **Top evidence pieces:**
   - Goldman Sachs $26 price target (9% below current) with Sell rating - VERIFIED across multiple sources
   - Historical pattern: 4 of 5 recent earnings produced double-digit drops - VERIFIED with two documented cases
   - Feb 3 earnings catalyst within prediction window - VERIFIED across all sources
   - Strong revenue guidance $10-11B vs $7.83B estimate - VERIFIED from earnings preview
   - No new positive developments or orders announced - VERIFIED from AskNews research

5. **Blind spot:** SMCI delivers blowout earnings with $11B+ revenue AND announces margin improvement initiatives that credibly address Goldman's concerns. Stock gaps up 10-15% on Feb 4 and sustains gains. This would make 37% look too pessimistic. Probability of this scenario: ~20%, already partially captured in the 37%.

6. **Status quo:** Current trend is downward (down 6.4% past month). Status quo suggests continued gradual decline to $27-28 range by Feb 14, which supports prediction of "No" (price not higher). The 37% "Yes" probability already accounts for potential reversal.

Probability: 37%